Article citationsMore>>

Ellis, P.A., Saccani-Jott, G., Clarke, R., Johnston, S.R.D., Anderson, E., Howell, A., A’Hern, R., Saltar, J., Detre, S., Nicholson, R., Robertson, J., Smith, I.E. and Dowsett, M. (1997) Induction of Apoptosis by Tamoxifen and ICI 192780 in Primary Breast Cancer. International Journal of Cancer, 72, 608-613. http://dx.doi.org/10.1002/(SICI)1097-0215(19970807)72:4<608::AID-IJC10>3.0.CO;2-7

has been cited by the following article:

• TITLE: Sensitivity Evaluation of Two Human Breast Cancer Cell Lines to Tamoxifen through Apoptosis Induction

  AUTHORS: Spencer Keene, Charles Azuelos, Shyamal K. Majumdar

  KEYWORDS: Tamoxifen, Apoptosis, MCF-7 and MDA-MB-231 Human Breast Cancer Cell Lines, Mitochondrial Membrane Potential Assay, Estrogen Receptor

  JOURNAL NAME: Open Journal of Apoptosis, Vol.3 No.4, October 24, 2014

  ABSTRACT: Tamoxifen citrate (TAM) has been used to treat breast cancer in women for many years. The com-parative effects of TAM in inducing apoptosis were evaluated in estrogen receptor-positive (ER- positive MCF-7) and estrogen receptor-negative (ER-negative MDA-MB-231) human breast cancer cell lines in vitro in order to determine if these two cell lines differ in their sensitivity to TAM. Mi-tochondrial membrane permeability potential disruption was assessed in both cell lines by a lip-ophilic cationic dye (DePsipher assay, Trevigen, Inc.) utilizing fluorescence microscopy. Using this specific fluorochrome, we were able to associate mitochondrial membrane disruption to early, mid-, and late apoptotic cells. TAM induced cell death via apoptosis in both ER-positive and ER- negative cells, however, apoptosis induction was more pronounced in ER-positive MCF-7 compared to ER-negative MDA-MB-231 breast cancer cells. These findings may have some therapeutic use in the treatment of estrogen dependent and estrogen independent breast cancer.